https://www.selleckchem.com/pr....oducts/afuresertib-g
33, 11.81 and 7.02 mm /year in quartile 4, compared to -3.44, -0.59 and 1.91 mm /year in quartile 1, respectively). No significant interaction was found for other study variables. Similar interactions were seen when assessing Lp(a) levels ≥50 mg/dL. Elevated Lp(a) was associated with an absolute increase in CAC volume, especially in participants with higher levels of selected markers of inflammation and coagulation. These results suggest Lp(a) as a potential biomarker for CAC volume progression. Elevated Lp(a) was associa